These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 7808021

  • 1. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM.
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [Abstract] [Full Text] [Related]

  • 2. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA.
    Saiag P, Pavlovic M, Clerici T, Feauveau V, Nicolas JC, Emile D, Chastang C.
    AIDS; 1998 Nov 12; 12(16):2169-76. PubMed ID: 9833858
    [Abstract] [Full Text] [Related]

  • 3. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
    Bernstein ZP, Chanan-Khan A, Miller KC, Northfelt DW, Lopez-Berestein G, Gill PS.
    Cancer; 2002 Dec 15; 95(12):2555-61. PubMed ID: 12467070
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
    Tulpule A, Joshi B, DeGuzman N, Espina BM, Mocharnuk R, Prakash O, Templeton D, Levine AM, Gill PS.
    Ann Oncol; 1997 Jan 15; 8(1):79-83. PubMed ID: 9093711
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
    Miles SA, Dezube BJ, Lee JY, Krown SE, Fletcher MA, Saville MW, Kaplan L, Groopman J, Scadden DT, Cooley T, Von Roenn J, Friedman-Kien A, AIDS Malignancy Consortium.
    AIDS; 2002 Feb 15; 16(3):421-9. PubMed ID: 11834954
    [Abstract] [Full Text] [Related]

  • 6. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS, Mitsuyasu RT, Montgomery T, Huang J, Cabriales S, Testa M, Espina BM, Levine AM, Miles SA.
    Cancer J Sci Am; 1997 Feb 15; 3(5):278-83. PubMed ID: 9327151
    [Abstract] [Full Text] [Related]

  • 7. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
    Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC.
    N Engl J Med; 1996 Oct 24; 335(17):1261-9. PubMed ID: 8857005
    [Abstract] [Full Text] [Related]

  • 8. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW, Remick SC, Azarnia N, Proper JA, Barrueco JR, Dezube BJ.
    Clin Cancer Res; 1999 Nov 24; 5(11):3432-7. PubMed ID: 10589755
    [Abstract] [Full Text] [Related]

  • 9. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
    Hermans P, Clumeck N, Picard O, van Vooren JP, Duriez P, Zucman D, Bryant JL, Gill P, Lunardi-Iskandar Y, Gallo RC.
    J Hum Virol; 1998 Nov 24; 1(2):82-9. PubMed ID: 10195236
    [Abstract] [Full Text] [Related]

  • 10. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
    Miles S, Levine A, Feldstein M, Carden J, Cabriallas S, Marcus S, Mitsuyasu R, Gill P.
    Cytokines Cell Mol Ther; 1998 Mar 24; 4(1):17-23. PubMed ID: 9557213
    [Abstract] [Full Text] [Related]

  • 11. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M, Weir J, Francis N, Newsom-Davis T, Powles S, Crook T, Boffito M, Gazzard B, Nelson M.
    AIDS; 2009 Aug 24; 23(13):1701-6. PubMed ID: 19550283
    [Abstract] [Full Text] [Related]

  • 12. [AIDS-associated Kaposi's sarcoma: 22 cases].
    Dhrif AS, Kilani B, Ammari L, Kanoun F, Tiouri H, Ben Chaaben T.
    Tunis Med; 2007 Jun 24; 85(6):494-9. PubMed ID: 17644904
    [Abstract] [Full Text] [Related]

  • 13. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
    Schwartsmann G, Sprinz E, Kromfield M, Kalakun L, Sander E, Prolla G, Di Leone L, Gerhardt L, Mans DR.
    J Clin Oncol; 1997 May 24; 15(5):2118-24. PubMed ID: 9164226
    [Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
    Amantea MA, Forrest A, Northfelt DW, Mamelok R.
    Clin Pharmacol Ther; 1997 Mar 24; 61(3):301-11. PubMed ID: 9084455
    [Abstract] [Full Text] [Related]

  • 15. Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study.
    Autier J, Picard-Dahan C, Marinho E, Grossin M, Yeni P, Leport C, Vildé JL, Crickx B, Descamps V.
    Br J Dermatol; 2005 May 24; 152(5):1026-9. PubMed ID: 15888164
    [Abstract] [Full Text] [Related]

  • 16. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
    Noy A, Scadden DT, Lee J, Dezube BJ, Aboulafia D, Tulpule A, Walmsley S, Gill P.
    J Clin Oncol; 2005 Feb 10; 23(5):990-8. PubMed ID: 15598977
    [Abstract] [Full Text] [Related]

  • 17. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
    Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS.
    Cancer; 2002 Jul 01; 95(1):147-54. PubMed ID: 12115328
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
    Shepherd FA, Evans WK, Garvey B, Read SE, Klein M, Fanning MM, Coates R.
    CMAJ; 1988 Oct 01; 139(7):635-9. PubMed ID: 2458177
    [Abstract] [Full Text] [Related]

  • 19. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.
    Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo M.
    Am J Med; 1991 Apr 01; 90(4):427-33. PubMed ID: 1707230
    [Abstract] [Full Text] [Related]

  • 20. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C, Chevret S, Blum L, Gauvillé C, Hurault M, Blanchard G, Agbalika F, Lascoux C, Ponscarme D, Morel P, Calvo F, Lebbé C.
    J Invest Dermatol; 2001 Oct 01; 117(4):858-63. PubMed ID: 11676823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.